[144] Marqeta, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice shows a proposed sale of 55,611 shares of common stock of the issuer, valued at $338,114.88, to be sold through Morgan Stanley Smith Barney LLC on or about 09/09/2025 on NASDAQ. The securities were acquired as restricted stock units from the issuer on 03/01/2024 and the filer reports no securities sold in the past three months.

The filing includes the seller's representation that they are not aware of any undisclosed material adverse information and references Rule 10b5-1 plan adoption language but provides no plan adoption date. The shares to be sold represent a small fraction of the 414,971,902 shares outstanding reported in the form.

Positive

• Transparency: The filer discloses the exact number of shares (55,611) and aggregate market value ($338,114.88).
• Brokered sale: Sale will be executed through a registered broker-dealer (Morgan Stanley Smith Barney LLC), following standard market procedures.
• Origin of shares disclosed: The securities were acquired as restricted stock units on 03/01/2024, clarifying source and nature of holdings.

Negative

• No 10b5-1 plan date provided: The filing references Rule 10b5-1 language but does not supply a plan adoption or instruction date.
• Limited context: The form provides no additional commentary on the purpose of the sale or any subsequent transactions beyond 'Nothing to Report' for the past three months.

Insights

Securities Analyst

TL;DR: Insider plans a routine sale of 55,611 RSU-derived shares, modest relative to outstanding float.

The notice documents an insider sale via broker for 55,611 shares valued at $338,114.88, originating from restricted stock units granted on 03/01/2024. Relative to the reported 414,971,902 shares outstanding, this is immaterial and unlikely to affect market liquidity or the share price materially. The filing does not report any sales in the past three months, and no 10b5-1 adoption date is provided, so timing appears to be a standard disclosure of intent to sell rather than a coordinated large disposition.

Corporate Governance Expert

TL;DR: Compliance disclosure appears standard; representation of no material nonpublic information is included but no plan date is given.

The Form 144 contains the customary attestation regarding material nonpublic information and identifies Morgan Stanley Smith Barney LLC as the broker. The filer acquired the shares as RSUs from the issuer and indicates cash payment was not applicable. The absence of a stated Rule 10b5-1 plan adoption date means investors cannot verify preplanned trading status from this form alone; however, the small size of the proposed sale reduces governance concerns from a market-impact perspective.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	55611	338114.88	414971902	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2024	Restricted Stock Units	Issuer			55611	03/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the Form 144 for Marqeta, Inc. (MQ)?

The filing notifies a proposed sale of 55,611 common shares valued at $338,114.88, to be sold via Morgan Stanley Smith Barney LLC on or about 09/09/2025 on NASDAQ.

How were the shares being sold acquired?

The shares were acquired as restricted stock units from the issuer on 03/01/2024.

Does the Form 144 report any sales in the past three months for the filer?

No. The filing states 'Nothing to Report' for securities sold during the past three months.

What fraction of outstanding shares does this proposed sale represent?

The filing reports 414,971,902 shares outstanding; the proposed sale of 55,611 shares is a de minimis fraction of that total.

Is there confirmation the sale is part of a Rule 10b5-1 trading plan?

The form references Rule 10b5-1 language but does not provide a plan adoption or instruction date, so it does not confirm a 10b5-1 plan in the filing.